niddk tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide (Mounjaro) In Sherman Oaks

However, studies on GLP-1 receptor agonists, the class of drugs to which semaglutide belongs, have shown that these medications can cause gastrointestinal side effects in some patients, especially when used for extended periods

The convergence of estrogen and GLP-1 signaling on metabolic and neuroinflammatory pathways supports the rationale for dual-targeted interventions

For instance, one study involving 76 patients with T1D using GLP-1RA, at 12 months had statistically significant reductions in weight, HbA1c and insulin requirement[66]

Importantly, many of these effects are temporary during active usage, with consumption rebounding after discontinuation

Though Ozempics stomach paralysis side effect is rare, it is something to monitor